These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27475276)

  • 1. Diffusion-weighted magnetic resonance imaging for evaluation of salivary gland function in head and neck cancer patients treated with intensity-modulated radiotherapy.
    Loimu V; Seppälä T; Kapanen M; Tuomikoski L; Nurmi H; Mäkitie A; Tenhunen M; Saarilahti K
    Radiother Oncol; 2017 Feb; 122(2):178-184. PubMed ID: 27475276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary gland function in nasopharyngeal carcinoma before and late after intensity-modulated radiotherapy evaluated by dynamic diffusion-weighted MR imaging with gustatory stimulation.
    Shi D; Qian JJ; Fan GH; Shen JK; Tian Y; Xu L
    BMC Oral Health; 2019 Dec; 19(1):288. PubMed ID: 31864328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted imaging as a follow-up modality for evaluation of major salivary gland function in nasopharyngeal carcinoma patients: a preliminary study.
    Fan WJ; Teng F; Luo YR; Yu W; Zhang Q; Lu YP; Ma L
    Strahlenther Onkol; 2020 Jun; 196(6):530-541. PubMed ID: 32025803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted magnetic resonance imaging to evaluate major salivary gland function before and after radiotherapy.
    Dirix P; De Keyzer F; Vandecaveye V; Stroobants S; Hermans R; Nuyts S
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1365-71. PubMed ID: 18355977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Salivary Gland Function Using Diffusion-Weighted Magnetic Resonance Imaging for Follow-Up of Radiation-Induced Xerostomia.
    Zhang Y; Ou D; Gu Y; He X; Peng W
    Korean J Radiol; 2018; 19(4):758-766. PubMed ID: 29962882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted MR imaging of salivary glands with gustatory stimulation: comparison before and after radiotherapy.
    Zhang Y; Ou D; Gu Y; He X; Peng W; Mao J; Yue L; Shen X
    Acta Radiol; 2013 Oct; 54(8):928-33. PubMed ID: 23821773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.
    Münter MW; Hoffner S; Hof H; Herfarth KK; Haberkorn U; Rudat V; Huber P; Debus J; Karger CP
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):651-9. PubMed ID: 17175118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective investigation and literature review of tolerance dose on salivary glands using quantitative salivary gland scintigraphy in the intensity-modulated radiotherapy era.
    Lee SW; Kang KW; Wu HG
    Head Neck; 2016 Apr; 38 Suppl 1():E1746-55. PubMed ID: 26875880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Changes in Apparent Diffusion Coefficient for Salivary Glands during Radiotherapy for Nasopharyngeal Carcinoma Associated with Xerostomia.
    Zhang Q; Wei YM; Qi YG; Li BS
    Korean J Radiol; 2018; 19(2):328-333. PubMed ID: 29520191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy requirements for head and neck intensity-modulated radiation therapy based on observed dose response of the major salivary glands.
    Kapanen M; Collan J; Saarilahti K; Heikkonen J; Kairemo K; Tenhunen M
    Radiother Oncol; 2009 Oct; 93(1):109-14. PubMed ID: 19435641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
    Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
    Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
    Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scintigraphy in prediction of the salivary gland function after gland-sparing intensity modulated radiation therapy for head and neck cancer.
    Tenhunen M; Collan J; Kouri M; Kangasmäki A; Heikkonen J; Kairemo K; Mäkitie A; Joensuu H; Saarilahti K
    Radiother Oncol; 2008 May; 87(2):260-7. PubMed ID: 18329118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical evaluation of post-radiotherapy salivary gland function using salivary gland scintigraphy.
    Itonaga T; Tokuuye K; Mikami R; Shimizu A; Sato H; Yoshimura M; Tsukahara K; Saito K
    Br J Radiol; 2022 Feb; 95(1130):20210718. PubMed ID: 34928174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: correlations with parotid dose and quality of life.
    Chen WC; Lai CH; Lee TF; Hung CH; Liu KC; Tsai MF; Wang WH; Chen H; Fang FM; Chen MF
    Oral Oncol; 2013 Jan; 49(1):42-8. PubMed ID: 22854066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on DWMRI in evaluating the influence of intensity modulated radiotherapy on salivary gland function of nasopharyngeal carcinoma patients].
    Li Y; Zhao C
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Sep; 50(9):754-9. PubMed ID: 26696349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors.
    Beetz I; Schilstra C; van der Schaaf A; van den Heuvel ER; Doornaert P; van Luijk P; Vissink A; van der Laan BF; Leemans CR; Bijl HP; Christianen ME; Steenbakkers RJ; Langendijk JA
    Radiother Oncol; 2012 Oct; 105(1):101-6. PubMed ID: 22516776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy.
    Rudat V; Münter M; Rades D; Grötz KA; Bajrovic A; Haberkorn U; Brenner W; Debus J
    Radiother Oncol; 2008 Oct; 89(1):71-80. PubMed ID: 18707782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative salivary gland scintigraphy in head and neck cancer patients following radiotherapy].
    Jiménez-Heffernan A; Gómez-Millán J; Sánchez De Mora E; Delgado Moreno J; Delgado Gil MM; Salgado C; Contreras Puertas P; Bermúdez Morales MC; López J; Paz Expósito J
    Rev Esp Med Nucl; 2010; 29(4):165-71. PubMed ID: 20462671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.